The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy
2019 · European Journal of Medicinal Chemistry · 145 citations
https://doi.org/10.1016/j.ejmech.2019.05.018
Y
Yu‐Shang Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
1.8K
Citations
23
h-index
52
i10-index
Yu‐Shang Yang is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Esophageal and GI Pathology. The author has an h-index of 23, co-authored 146 publications.
ORCID: 0000-0001-5100-2266Papers by this author
worksFolate-mediated one-carbon metabolism: a targeting strategy in cancer therapy
2020 · Drug Discovery Today · 112 citations
https://doi.org/10.1016/j.drudis.2020.12.006
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial
2024 · British Journal of Cancer · 15 citations
https://doi.org/10.1038/s41416-024-02805-5
Mendelian randomization analysis of atopic dermatitis and esophageal cancer in East Asian and European populations
2024 · World Allergy Organization Journal · 5 citations
https://doi.org/10.1016/j.waojou.2023.100868
Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway
2023 · Heliyon · 4 citations
https://doi.org/10.1016/j.heliyon.2023.e23832
Clinical efficacy of different therapeutic strategies in patients with spontaneous rupture of the esophagus: a multicenter retrospective cohort study
2024 · International Journal of Surgery · 4 citations
https://doi.org/10.1097/js9.0000000000001911
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat